Furthermore, following the 6 h incubation with CML or acrylamide, the expression of MUC5AC mRNA was significantly lowered (p < 0.0001 for both) by 0.6-fold and 0.4-fold, respectively (Figure 5c). This evidence concerns the gene MUC5AC and chronic myelogenous leukemia, BCR-ABL1 positive.